Jump to navigation

Search form

Home

Selcia

Drug Discovery & Radiolabelling
  • Home
  • About Selcia
    • Key Facts
    • Our Approach
    • Senior Management
    • Facilities & Accreditations
    • History
  • Drug Discovery
    • Medicinal Chemistry
    • Natural Product Chemistry and Structural Biology
    • Assay Development and Screening
    • ADME/PK
    • PPIase Services
    • Target Class and Disease Expertise
  • Radiolabelling
    • C-14 Custom Radiolabelling
    • 14C-Isotope of choice
    • Carbon-14 API to GMP
    • GLP Analytical and Metabolite Synthesis
    • Quality System
    • Techniques & Equipment
    • Industries
    • Registration Studies using 14C
    • REACH – 14C-Regulatory requirements
  • Chemistry & Analytics
    • Custom Synthesis
    • Crop Science Expertise
    • Analytical and Separation Sciences
  • News & Events
  • Resources
    • Literature
    • Selcia Brochures
    • Partners
  • Careers
  • Contact Us

2015 News | Events | Industry Updates

07 December 2015
Selcia scientists to provide medicinal chemistry and PPIase screening to support Cypralis’s collaboration with Johnson & Johnson Innovation in the field of neurodegenerative diseases
30 November 2015
University of Edinburgh and Selcia Achieve Key Milestones in Bid to Develop New Drugs to Target Sleeping Sickness
02 November 2015
Selcia Working with Cypralis to Generate New Class of Selective Cyclophilin D Inhibitors
20 October 2015
Selcia constructs new 14C GMP API manufacturing suite

Selcia increases capacity with construction of a new dedicated 14C GMP API manufacturing suite.

07 October 2015
Selcia Chemists Co-author Poster on Anti-Infectives

Selcia chemists are co-authors on a poster presented by Cantab Anti-Infectives at ICAAC.

Pages

  • 1
  • 2
  • next ›
  • last »
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
View as RSS

Contact us today

Contact us today

+44 (0) 1277 367 000
contact@selcia.com

Upcoming Events

There are currently no scheduled events.

  • Drug Discovery
    • Medicinal Chemistry
    • Natural Product Chemistry and Structural Biology
    • Assay Development & Screening
    • ADME/PK
    • PPIase Services
    • Target Class and Disease Expertise
  • Radiolabelling
    • C-14 Custom Radiolabelling
    • 14C-Isotope of choice
    • Carbon-14 API to GMP
    • GLP Analysis and Metabolite Synthesis
    • Quality System
    • Techniques & Equipment
    • Industries
    • Registration Studies using 14C
    • REACH – 14C-Regulatory requirements
  • Chemistry & Analytics
    • Custom Synthesis
    • Crop Science Expertise
    • Analytical and Separation Sciences
  • Other
    • News & Events
    • Resources
    • Careers
    • Contact Us
    • Key Facts
    • Our Approach
    • Management team
    • Facility & Accreditions
    • History
    • COVID-19 Risk Assessment

Legal Notice  |  Privacy Policy  |  Accessibility  |  Sitemap

Copyright © 2025 Selcia Limited, all rights reserved

Selcia is now part of Eurofins. Read the press release to find out more. X